OtherToxicology
Proteomic analysis of rat liver phosphoproteins following treatment with protein kinase inhibitor H89 (N-(2-[p- bromocinnamylamino-]ethyl)-5-isoquinoline-sulfonamide)
Myrtle Davis, Douglas Hinerfeld, Sajan Joseph, Yu-Hua Hui, John Leszyk, Naijia H. Huang, Jennifer Rutherford-Bethard and Sun W. Tam
Journal of Pharmacology and Experimental Therapeutics May 10, 2006, DOI: https://doi.org/10.1124/jpet.105.100032
Myrtle Davis
Douglas Hinerfeld
Sajan Joseph
Yu-Hua Hui
John Leszyk
Naijia H. Huang
Jennifer Rutherford-Bethard
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
OtherToxicology
Proteomic analysis of rat liver phosphoproteins following treatment with protein kinase inhibitor H89 (N-(2-[p- bromocinnamylamino-]ethyl)-5-isoquinoline-sulfonamide)
Myrtle Davis, Douglas Hinerfeld, Sajan Joseph, Yu-Hua Hui, John Leszyk, Naijia H. Huang, Jennifer Rutherford-Bethard and Sun W. Tam
Journal of Pharmacology and Experimental Therapeutics May 10, 2006, DOI: https://doi.org/10.1124/jpet.105.100032
OtherToxicology
Proteomic analysis of rat liver phosphoproteins following treatment with protein kinase inhibitor H89 (N-(2-[p- bromocinnamylamino-]ethyl)-5-isoquinoline-sulfonamide)
Myrtle Davis, Douglas Hinerfeld, Sajan Joseph, Yu-Hua Hui, John Leszyk, Naijia H. Huang, Jennifer Rutherford-Bethard and Sun W. Tam
Journal of Pharmacology and Experimental Therapeutics May 10, 2006, DOI: https://doi.org/10.1124/jpet.105.100032
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement